‹ INDV latest research

INDV (Indivior Pharmaceuticals, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed INDV on 7 market nights between May 28, 2026 and September 1, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

7 calls 4 BUY · 3 HOLD · 0 SELL BUY calls up after 20 trading days: 2 of 4
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
September 1, 2026 HOLD $34.93 — / — +0.6% +3.7%
The current market regime is neutral, and INDV presents conflicting signals with a bearish technical outlook despite insider buying and a bullish fundamental view.
August 28, 2026 HOLD $35.30 — / — +0.2% +5.8%
Strong Q2 earnings beat and raised 2026 outlook.
August 7, 2026 BUY $38.67 — / — +0.5% -10.0%
The stock is currently below key technical support and the risk profile is high, necessitating a wait-and-see approach.
July 21, 2026 BUY $39.12 $41.76 / $31.62 +1.3% -2.5%
The scanner trigger suggests a short-term mean-reversion opportunity, while the fundamental and sentiment teams provide a longer-term bullish outlook.
June 1, 2026 BUY $36.02 $39.36 / $28.90 +7.2% +17.6%
The scanner trigger suggests a short-term mean-reversion opportunity, while the fundamental and sentiment teams point to longer-term upside.
May 29, 2026 HOLD $36.61 — / — +4.4% +14.6%
The current market regime is neutral, and INDV presents a high-risk profile with mixed directional team signals, necessitating a cautious approach.
May 28, 2026 BUY $37.11 $44.53 / $31.54 +2.3% +14.3%
The bullish fundamental and sentiment outlook, combined with a technical pullback, suggests a medium-term upward trend.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.